2pkf: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Adenosine kinase (ADK) catalyzes the phosphorylation of adenosine (Ado) to, adenosine monophosphate (AMP). It is part of the purine salvage pathway, that has been identified only in eukaryotes, with the single exception of, Mycobacterium spp. Whereas it is not clear if Mycobacterium tuberculosis, (Mtb) ADK is essential, it has been shown that the enzyme can selectively, phosphorylate nucleoside analogs to produce products toxic to the cell. We, have determined the crystal structure of Mtb ADK unliganded as well as, ligand (Ado) bound at 1.5- and 1.9-A resolution, respectively. The, structure of the binary complexes with the inhibitor 2-fluoroadenosine, (F-Ado) bound and with the adenosine 5'-(beta,gamma-methylene)triphosphate, (AMP-PCP) (non-hydrolyzable ATP analog) bound were also solved at 1.9-A, resolution. These four structures indicate that Mtb ADK is a dimer formed, by an extended beta sheet. The active site of the unliganded ADK is in an, open conformation, and upon Ado binding a lid domain of the protein, undergoes a large conformation change to close the active site. In the, closed conformation, the lid forms direct interactions with the substrate, and residues of the active site. Interestingly, AMP-PCP binding alone was, not sufficient to produce the closed state of the enzyme. The binding mode, of F-Ado was characterized to illustrate the role of additional, non-bonding interactions in Mtb ADK compared with human ADK.
Adenosine kinase (ADK) catalyzes the phosphorylation of adenosine (Ado) to adenosine monophosphate (AMP). It is part of the purine salvage pathway that has been identified only in eukaryotes, with the single exception of Mycobacterium spp. Whereas it is not clear if Mycobacterium tuberculosis (Mtb) ADK is essential, it has been shown that the enzyme can selectively phosphorylate nucleoside analogs to produce products toxic to the cell. We have determined the crystal structure of Mtb ADK unliganded as well as ligand (Ado) bound at 1.5- and 1.9-A resolution, respectively. The structure of the binary complexes with the inhibitor 2-fluoroadenosine (F-Ado) bound and with the adenosine 5'-(beta,gamma-methylene)triphosphate (AMP-PCP) (non-hydrolyzable ATP analog) bound were also solved at 1.9-A resolution. These four structures indicate that Mtb ADK is a dimer formed by an extended beta sheet. The active site of the unliganded ADK is in an open conformation, and upon Ado binding a lid domain of the protein undergoes a large conformation change to close the active site. In the closed conformation, the lid forms direct interactions with the substrate and residues of the active site. Interestingly, AMP-PCP binding alone was not sufficient to produce the closed state of the enzyme. The binding mode of F-Ado was characterized to illustrate the role of additional non-bonding interactions in Mtb ADK compared with human ADK.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Mycobacterium tuberculosis]]
[[Category: Mycobacterium tuberculosis]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Owen, J.L.]]
[[Category: Owen, J L.]]
[[Category: Palaninathan, S.K.]]
[[Category: Palaninathan, S K.]]
[[Category: Reddy, M.C.M.]]
[[Category: Reddy, M C.M.]]
[[Category: Sacchettini, J.C.]]
[[Category: Sacchettini, J C.]]
[[Category: Shetty, N.D.]]
[[Category: Shetty, N D.]]
[[Category: TBSGC, TB.Structural.Genomics.Consortium.]]
[[Category: TBSGC, TB Structural Genomics Consortium.]]
[[Category: Watson, M.D.]]
[[Category: Watson, M D.]]
[[Category: adenosine kinase]]
[[Category: adenosine kinase]]
[[Category: mycobacterium tuberculosis]]
[[Category: mycobacterium tuberculosis]]
Line 28: Line 28:
[[Category: transferase]]
[[Category: transferase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 13 08:17:57 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:30:24 2008''

Revision as of 19:30, 21 February 2008

File:2pkf.jpg


2pkf, resolution 1.50Å

Drag the structure with the mouse to rotate

Crystal structure of M tuberculosis Adenosine Kinase (apo)

OverviewOverview

Adenosine kinase (ADK) catalyzes the phosphorylation of adenosine (Ado) to adenosine monophosphate (AMP). It is part of the purine salvage pathway that has been identified only in eukaryotes, with the single exception of Mycobacterium spp. Whereas it is not clear if Mycobacterium tuberculosis (Mtb) ADK is essential, it has been shown that the enzyme can selectively phosphorylate nucleoside analogs to produce products toxic to the cell. We have determined the crystal structure of Mtb ADK unliganded as well as ligand (Ado) bound at 1.5- and 1.9-A resolution, respectively. The structure of the binary complexes with the inhibitor 2-fluoroadenosine (F-Ado) bound and with the adenosine 5'-(beta,gamma-methylene)triphosphate (AMP-PCP) (non-hydrolyzable ATP analog) bound were also solved at 1.9-A resolution. These four structures indicate that Mtb ADK is a dimer formed by an extended beta sheet. The active site of the unliganded ADK is in an open conformation, and upon Ado binding a lid domain of the protein undergoes a large conformation change to close the active site. In the closed conformation, the lid forms direct interactions with the substrate and residues of the active site. Interestingly, AMP-PCP binding alone was not sufficient to produce the closed state of the enzyme. The binding mode of F-Ado was characterized to illustrate the role of additional non-bonding interactions in Mtb ADK compared with human ADK.

About this StructureAbout this Structure

2PKF is a Single protein structure of sequence from Mycobacterium tuberculosis. Active as Adenosine kinase, with EC number 2.7.1.20 Full crystallographic information is available from OCA.

ReferenceReference

High resolution crystal structures of Mycobacterium tuberculosis adenosine kinase: insights into the mechanism and specificity of this novel prokaryotic enzyme., Reddy MC, Palaninathan SK, Shetty ND, Owen JL, Watson MD, Sacchettini JC, J Biol Chem. 2007 Sep 14;282(37):27334-42. Epub 2007 Jun 26. PMID:17597075

Page seeded by OCA on Thu Feb 21 18:30:24 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA